Showing results (51-60 of 104) with videos related to

Sort By:
Pageof 11
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|October 1, 1992
Hereditary deficiency of antithrombin III, protein C and protein S: prevalence in patients with a history of venous thrombosis and criteria for rational patient screeningI Pabinger, S Brücker, P A Kyrle, et al.
Annals of Hematology|May 10, 2003
Efficacy and safety of splenectomy in adult chronic immune thrombocytopeniaC Zoghlami-Rintelen, A Weltermann, C Bittermann, et al.
British Journal of Haematology|May 1, 1988
IIB von Willebrand's disease: pathogenetic and therapeutic studiesP A Kyrle, H Niessner, J Dent, et al.
Thrombosis and Haemostasis|April 1, 1997
Inhibition rather than enhancement of hemostatic system activation during initiation of oral anticoagulant treatmentP A Kyrle, J Brockmeier, A Weltermann, et al.
European Journal of Clinical Investigation|June 4, 2009
Thrombin generation in haemophilia A patients with factor VIII inhibitors after infusion of recombinant factor VIIaS Eichinger, B Lubsczyk, M Kollars, et al.
Journal of Thrombosis and Haemostasis : JTH|July 23, 2003
The risk of recurrent venous thromboembolism among patients with high factor IX levelsA Weltermann, S Eichinger, C Bialonczyk, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|April 7, 1999
No evidence for an increased risk of venous thrombosis in patients with factor V Leiden by the homozygous 677 C to T mutation in the methylenetetrahydrofolate-reductase geneC Rintelen, C Mannhalter, K Lechner, et al.
Journal of Thrombosis and Haemostasis : JTH|October 4, 2016
The long-term recurrence risk of patients with unprovoked venous thromboembolism: an observational cohort studyP A Kyrle, M Kammer, L Eischer, et al.
Pageof 11